CURRENT CLINICAL PHARMACOLOGY, vol.15, no.2, pp.164-169, 2020 (ESCI, Scopus)
Background: Neonatal Respiratory Distress Syndrome (NRDS) is one of the most frequent causes of neonatal mortality especially in premature infants. Although it has been well established that maternal antenatal corticosteroid therapy has a positive effect on NRDS reduction, yet the effectiveness of this treatment in multifetal pregnancies is dubious.